ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 686514 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 686514; 2) Community: the network communities that were significantly associated with the response to NSC 686514; 3) Molecule: the relationships between components within communities and NSC 686514; 4) MDR: the compounds that were significantly associated with the NSC 686514.

NSC Compound Enrichment Correlation
NSC 292567 Nigericin sodium salt 0.00148966185497003 0.50765183
NSC 734278 Null 0.00209154338952974 0.2302255
NSC 633781 1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate 0.00209154338952976 -0.047345048
NSC 658140 Null 0.00209154338952976 -0.0083739094
NSC 676788 Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-L-arabinopyranosyl] ester 0.00209154338952976 -0.1265047
NSC 681634 Camptothecin Derivative 0.00209154338952976 -0.10380411
NSC 701022 Null 0.00243861794188205 0.11603964
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.00243861794188205 -0.024505238
NSC 732492 Null 0.00243861794188205 0.0064543024
NSC 106557 5.alpha.,25D-Spirostan-3.beta.-ol glycoside 0.00243861794188209 0.012585905
Total:35  Current:2    [First] [Prev] [Next] [Last]